No Data
No Data
Investors in Crinetics Pharmaceuticals (NASDAQ:CRNX) Have Seen Solid Returns of 196% Over the Past Three Years
Crinetics(CRNX.US) Officer Sells US$5.31 Million in Common Stock
$Crinetics(CRNX.US)$ Officer Struthers Richard Scott sold 107.45K shares of common stock on May 8, 2024 at an average price of $49.4 for a total value of $5.31 million.Source: Announcement What is sta
Express News | Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing
Richard Scott Struthers, Director, President & CEO, on May 08, 2024, sold 107,448 shares in Crinetics Pharmaceuticals (CRNX) for $5,307,931. Following the Form 4 filing with the SEC, Struthers has con
Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co.
Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co.
Crinetics Pharmaceuticals Inc (CRNX) Reports Q1 2024 Financial Results